ID: ALA538725

Max Phase: Preclinical

Molecular Formula: C13H20ClNO

Molecular Weight: 205.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)N1CCC(c2cccc(O)c2)C1.Cl

Standard InChI:  InChI=1S/C13H19NO.ClH/c1-10(2)14-7-6-12(9-14)11-4-3-5-13(15)8-11;/h3-5,8,10,12,15H,6-7,9H2,1-2H3;1H

Standard InChI Key:  DTDXJMIAWZVQRL-UHFFFAOYSA-N

Associated Targets(non-human)

Dopamine receptor 1304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 205.30Molecular Weight (Monoisotopic): 205.1467AlogP: 2.59#Rotatable Bonds: 2
Polar Surface Area: 23.47Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.18CX Basic pKa: 9.37CX LogP: 2.16CX LogD: 0.48
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.80Np Likeness Score: -0.65

References

1. Hacksell U, Arvidsson LE, Svensson U, Nilsson JL, Sanchez D, Wikström H, Lindberg P, Hjorth S, Carlsson A..  (1981)  3-Phenylpiperidines. Central dopamine-autoreceptor stimulating activity.,  24  (12): [PMID:6796690] [10.1021/jm00144a021]

Source